Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: September 2015
-
By Kevin E. Noonan — Sandoz is having a good year. The company succeeded in having their NEUPOGEN® (filgrastrim) biosimilar product, Zarxio™, approved by the FDA in March, a mere ten months after filing its biosimilar application last July. The biosimilar applicant also avoided the disclosure provisions of the Biologics Price Competition and Innovation Act…
-
Julian Cockbain, a former partner at the UK patent firm Dehns, sent us the following request: Could I ask a favour? That you ask on your blog that readers send me copies of papers or theses that they have written on the subject of patent-eligibility (what is the proper subject matter for patents rather than…
-
September 8, 2015 – Patent Quality Chat webinar on Global Patent Prosecution (U.S. Patent and Trademark Office) – 12:00 to 1:00 pm (EDT) September 9, 2015 – "A Kinder, Gentler PTAB? Proposed New Trial Rules & Important Recent Decisions" (Intellectual Property Owners Association) – 2:00 to 3:00 pm (ET) September 9, 2015 – "Where to Challenge…
-
Amicus Briefs in Support of Sequenom’s Petition for Rehearing En Banc: Professors Lefstin and Menell
By Donald Zuhn — Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity of the asserted claims of U.S. Patent No. 6,258,540 (see "Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015)"). Last month,…
-
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "A Kinder, Gentler PTAB? Proposed New Trial Rules & Important Recent Decisions" on September 9, 2015 from 2:00 to 3:00 pm (ET). Hon. Michael Tierney, Lead Administrative Patent Judge, Patent Trial and Appeal Board, U.S. Patent & Trademark Office; Steven Baughman of Ropes…
-
Practising Law Institute (PLI) will be offering a one-hour webcast entitled "Where to Challenge Patents? International Post Grant Practice — Strategic Considerations Before the USPTO, EPO, SIPO and JPO" on September 9, 2015 from 1:00 to 2:00 pm (Eastern). Dr. Jeffery P. Langer, Christophe Besnard, Shigeki Takeuchi, and Cliff Yang of Osha Liang LLP will:…
-
American Conference Institute (ACI) will be holding the next session of its FDA Boot Camp conference on September 30 to October 1, 2015 in Boston, MA. ACI faculty will help attendees: • Master the basics of the application and approval processes for drugs, biologics, and devices;• Comprehend the structure of the FDA and the roles…
-
American Conference Institute (ACI) will be holding its 3rd Annual Paragraph IV Disputes master symposium from September 30 to October 1, 2014 in Chicago, IL. ACI faculty will provide insights into: • Paragraph IV Due Diligence Strategies Analyses• Pending Patent Reform Legislation and Its Potential Impact on Hatch-Waxman Litigation• Personal and General Jurisdiction Challenges Under…
-
The U.S. Patent and Trademark Office will be offering the next webinar in its Patent Quality Chat webinar series on September 8, 2015 from 12:00 to 1:00 pm (EDT). The latest webinar, which will be hosted by Deputy Commissioner for International Patent Cooperation Mark Powell and Director of International Programs Maria Holtmann, will address the…
-
By Donald Zuhn — Earlier this summer, in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the Federal Circuit affirmed a decision by the District Court for the Northern District of California granting summary judgment of invalidity of the asserted claims of U.S. Patent No. 6,258,540 (see "Ariosa Diagnostics, Inc. v. Sequenom, Inc. (Fed. Cir. 2015)"). On August…
Patent Docs 